Shinichiro Nakajima, MD

JCP
Original Research

February 11, 2020

Can overall response to antipsychotics be predicted by early improvements in individual symptoms among Alzheimer's disease patients? The current report analyzes the CATIE-AD phase 1 dataset in an attempt...
Tomoyuki Nagata, Shunichiro Shinagawa, Kazunari Yoshida, et al
JCP
Original Research

October 10, 2017

Although anosognosia—or impaired illness awareness—is common in Alzheimer's disease, it occurs less frequently in mild cognitive impairment. Read this article to learn if anosognosia in patients with mild cognitive...
Philip Gerretsen, Jun Ku Chung, Parita Shah, et al
JCP
Article

December 28, 2016

Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3...
Yusuke Iwata, Shinichiro Nakajima, Fernando Caravaggio, et al
JCP
Article

April 22, 2015

Fumihiko Ueno, Shinichiro Nakajima, Takefumi Suzuki, et al
JCP
Letter to the Editor

August 15, 2009

Shinichiro Nakajima, Hiroyuki Uchida, Takefumi Suzuki, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe